Schistosomiasis is diagnosed primarily by finding parasite eggs in stool or urine samples under a microscope. The specific test depends on which species of the parasite you were exposed to: stool examination for intestinal schistosomiasis, urine filtration for urogenital schistosomiasis. For travelers and people with light infections, blood antibody tests and DNA-based tests offer higher sensitivity when egg counts are too low to spot under a microscope.
Timing matters. Testing too early after exposure will produce a false negative, since the parasites need several weeks to mature and start producing eggs. Understanding which test to ask for, when to get it, and what the results mean can save you weeks of uncertainty.
When Testing Becomes Accurate
After you’re exposed to contaminated freshwater, the parasites penetrate your skin and travel through your bloodstream to the blood vessels around your intestines or bladder. Female worms begin laying eggs roughly four weeks after infection. However, those eggs don’t always show up immediately in lab samples, and your immune system needs time to produce detectable antibodies.
The CDC recommends waiting at least 6 to 8 weeks after your likely exposure before getting a blood antibody test. This window allows the parasites to fully mature and gives your immune system time to mount a measurable response. Stool and urine tests that look for eggs follow a similar timeline, since eggs won’t appear in your samples until the worms are actively producing them. Getting tested before this window closes is the most common reason for a falsely reassuring result.
Stool Microscopy for Intestinal Species
The WHO-recommended method for detecting intestinal schistosomiasis is the Kato-Katz thick smear technique. A technician takes a tiny amount of stool (about 42 milligrams), presses it onto a glass slide, and examines it under a light microscope for characteristic eggs. The slides need to be read within 20 to 30 minutes of preparation for the most accurate count, and ideally the stool sample should be analyzed the same day it’s collected.
This technique works well for moderate and heavy infections but has a significant blind spot: it misses many light infections. A single stool slide detects only a fraction of true cases. In one study of a population in a low-transmission area, a single slide identified just 13.8% of infected people, while examining 10 slides from three separate stool samples collected on different days caught 27.2%. The true prevalence, determined by the most exhaustive testing available, was 35.4%. That means a single sample missed roughly 6 out of 10 infections.
This is why doctors in non-endemic settings often request stool samples collected on multiple consecutive days. Each additional sample increases the odds of catching eggs that are shed intermittently. If your first result comes back negative but your exposure history is concerning, repeat testing is standard practice.
Urine Filtration for Urogenital Species
For urogenital schistosomiasis, the diagnostic standard is examining a filtered urine sample for eggs. The WHO recommends passing 10 milliliters of urine through a filter with pores small enough to trap the eggs (12 to 20 micrometers), then examining the filter under a microscope.
Collection timing affects accuracy. Egg excretion in urine peaks around midday, so samples collected between 10:00 a.m. and 2:00 p.m. yield the best results. A sample collected first thing in the morning or late in the afternoon may contain fewer eggs and is more likely to produce a false negative. Visible blood in the urine (or blood detected on a simple dipstick test) is also used as a screening indicator in endemic areas, since the eggs damage blood vessels in the bladder wall as they pass through.
Blood Antibody Tests
Antibody testing (serology) is the most useful option for travelers and people living outside endemic regions who had a single freshwater exposure. A blood sample is drawn and tested for antibodies your immune system produces specifically against schistosome proteins. This test is more sensitive than microscopy for light infections, which are common in people who had brief or one-time exposure.
The main limitation is that antibodies can persist in your blood long after a successful treatment. If you’ve been infected and treated before, a positive antibody test can’t tell you whether you have a new active infection or are simply carrying leftover antibodies from a past one. For this reason, serology is most informative as a first-time diagnostic tool rather than a way to confirm reinfection or monitor treatment success.
PCR and DNA-Based Tests
Polymerase chain reaction (PCR) testing detects parasite DNA in stool or urine and is considerably more sensitive than microscopy. In one study of imported schistosomiasis cases, PCR detected the urogenital species in 10.5% of urine samples compared to just 4% by microscopy, a 2.6-fold improvement. For the intestinal species in stool, PCR found infections in 48.8% of samples versus 33.7% by microscopy. Every sample that was positive under the microscope was also confirmed by PCR, meaning PCR catches everything microscopy catches plus additional cases that microscopy misses.
PCR is especially valuable for low-burden infections, which are exactly the type most travelers carry. The downside is availability. PCR requires specialized laboratory equipment and trained personnel, so it’s typically offered at reference labs or tropical medicine centers rather than standard clinics. If you’re being evaluated at a travel medicine clinic or a tropical disease unit at a major hospital, PCR is worth asking about.
Rapid Urine Antigen Tests
A point-of-care urine test that detects a protein (circulating cathodic antigen) released by living adult worms has been commercially available since 2005. It works like a pregnancy test strip: you apply urine and read the result in minutes. This makes it practical for large-scale screening in endemic areas where lab infrastructure is limited.
The test is most sensitive for intestinal schistosomiasis and performs less reliably for the urogenital species. Specificity has varied across studies. In one evaluation, specificity reached 99% in children from non-endemic areas, but dropped to 53-67% in certain populations when faint “trace” results were counted as positive. Trace readings are a known source of ambiguity with this test. It’s primarily a field screening tool rather than a definitive diagnostic, and a positive result is often followed up with microscopy or PCR for confirmation.
Ultrasound for Chronic Infections
Ultrasound doesn’t detect the parasite directly but can reveal the organ damage caused by long-standing infections. For intestinal schistosomiasis, ultrasound of the liver may show a distinctive pattern of scarring around the portal blood vessels (periportal fibrosis), enlargement of the left lobe of the liver, thickening of the gallbladder wall, and an enlarged spleen. Widened portal vessels and, in severe cases, blood clots in the portal vein can also appear.
For urogenital schistosomiasis, ultrasound of the bladder can reveal wall thickening, calcification, and structural changes in the kidneys or ureters caused by chronic egg deposition. These findings help doctors assess how much damage has occurred and guide treatment decisions, but they aren’t useful for detecting early or light infections before organ changes develop.
Which Test to Request
Your situation determines the best approach. If you’re a traveler who swam in a lake or river in sub-Saharan Africa, Southeast Asia, or South America and it’s been at least 6 to 8 weeks since exposure, start with a blood antibody test. If antibodies come back positive, stool and urine microscopy (or PCR if available) can confirm active infection and identify the species.
If you’re being evaluated in a tropical medicine clinic, you may be offered PCR upfront alongside microscopy, which maximizes the chance of catching a light infection in a single visit. Providing stool samples from two or three consecutive days significantly improves detection rates if microscopy is the only option available.
For people who grew up in endemic areas and have a history of prior infections and treatment, antibody testing alone isn’t reliable. Microscopy or antigen testing is more appropriate for distinguishing active infection from immunological memory of past exposure. Ultrasound adds value when long-term organ involvement is suspected.